Recruiting

Observational Study

Sponsor:

Global Research Institute

Code:

NCT05823779

Conditions

HIV Disease

Herpes Simplex 1

Herpes Simplex 2

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Blood draw

Study Details

Brief summary:

This study is an observational, cohort, prospective study looking at the frequency of Herpes Simplex Virus (HSV) 1 and or 2 outbreaks in HIV positive patients who's HIV virus is controlled on highly active anti-retroviral therapy. We will be enrolling fifty (50) patients.

Conditions

HIV Disease

Herpes Simplex 1

Herpes Simplex 2

Study ID

NCT05823779

Start date

Apr 1, 2022

Status verified date

Apr, 2023

Completion date

Apr 1, 2025

Anticipated

Primary completion date

Dec 31, 2024

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

1. Subject must be 18 years or older at the time of screening
2. Males, Females, Transgender Male and Transgender Females
3. HIV positive
4. Positive antibody to HSV- 1/and or HSV-2
5. If Female of child baring potential, documented negative pregnancy test at the time of screening.

Exclusion Criteria:

1. Active opportunistic infection
2. Current chemotherapy
3. Unable to give informed consent

Study Design

Enrollment

50 participants

Anticipated

Interventions and Outcome Measures

Interventions

Blood draw

We will be drawing blood for verify HIV status, HSV 1 or 2 antibodies, CD4 and HIV-PCR

Primary outcome measure

  • Epidemiology [ Time Frame: 48 weeks ]

Central Contacts and Locations

Central contacts

Jorge E Rodriguez, M.D.

(323) 934-36902jrodmd@gmail.com

Michael S Gottlieb, M.D.

(323) 215-1725drmichael.gottlieb@gmail.com

Locations

Global Research Institute

Recruiting

Los Angeles, California, United States, 90036

Contacts

Jorge E Rodrigiuez, MD

323-934-36902jrodmd@gmail.com

Michael S Gottlieb, M.D.

(323) 215-1725drmichael.gottlieb@gmail.com

Principal Investigator:

Jorge E Rodriguez, MD

More Information

Sponsor

Global Research Institute

Last update posted

Apr 21, 2023

Last verified

Apr, 2023

Keywords

  • HIV, Herpes Simplex 1, Herpes Simplex 2

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-10. This information was provided to ClinicalTrials.gov by Global Research Institute on 2023-04-21. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.